Life science and healthcare companies have many avenues available to raise capital at various stages, each with its own benefits and considerations. Savvy founders and startup leaders should understand which asset class can offer the best opportunity to advance and support their company’s success. Across all sectors – therapeutics, diagnostics, tools, medical devices and digital health – the approach you take today to create your syndicate of investors will impact all future funding rounds.
{iframe}https://www.jpmorgan.com/commercial-banking/insights/life-sciences-funding{/iframe}